gdme0222rdb - south and central america drug delivery ... · sample south and central america drug...

SAMPLE

South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central

Venous Catheters and Others GDME0222RDB / Published January 2013

© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form

South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Reference Code: GDME0222RDB

Publication Date: January 2013

SAMPLETable of Contents




1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 9

2.1 What is This Report About? 9

3 Drug Delivery Devices in South and Central America 10

3.1 Drug Delivery Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10

3.2 Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 11

3.3 Drug Delivery Devices, South and Central America, Company share (2010-2011) 18

4 Drug Delivery Devices In Argentina 20

4.1 Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 20

4.2 Drug Delivery Devices, Argentina, Distribution Share (2010-2011) 26 4.2.1 Central Venous Catheters, Argentina, Distribution Share (2010-2011) 26 4.2.2 Infusion Systems, Argentina, Distribution Share (2010-2011) 26 4.2.3 Metered Dose Inhaler Devices, Argentina, Distribution Share (2010-2011) 27 4.2.4 Needle Free Injections, Argentina, Distribution Share (2010-2011) 27

4.3 Drug Delivery Devices, Argentina, Company Share (2010-2011) 28 4.3.1 Drug Delivery Devices, Argentina, Company Share (2010-2011) 28 4.3.2 Central Venous Catheters, Argentina, Company Share (2010-2011) 30 4.3.3 Infusion Systems, Argentina, Company Share (2010-2011) 32 4.3.4 Metered Dose Inhaler Devices, Argentina, Company Share (2010-2011) 34 4.3.5 Needle Free Injections, Argentina, Company Share (2010-2011) 35

5 Drug Delivery Devices In Brazil 36

5.1 Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 36





5.2 Drug Delivery Devices, Brazil, Distribution Share (2010-2011) 42 5.2.1 Central Venous Catheters, Brazil, Distribution Share (2010-2011) 42 5.2.2 Infusion Systems, Brazil, Distribution Share (2010-2011) 42 5.2.3 Metered Dose Inhaler Devices, Brazil, Distribution Share (2010-2011) 43 5.2.4 Needle Free Injections, Brazil, Distribution Share (2010-2011) 43

5.3 Drug Delivery Devices, Brazil, Company Share (2010-2011) 44 5.3.1 Drug Delivery Devices, Brazil, Company Share (2010-2011) 44 5.3.2 Central Venous Catheters, Brazil, Company Share (2010-2011) 46 5.3.3 Infusion Systems, Brazil, Company Share (2010-2011) 48 5.3.4 Metered Dose Inhaler Devices, Brazil, Company Share (2010-2011) 50 5.3.5 Needle Free Injections, Brazil, Company Share (2010-2011) 51

6 Drug Delivery Devices in Mexico 52

6.1 Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 52

6.2 Drug Delivery Devices, Mexico, Distribution Share (2010-2011) 58 6.2.1 Central Venous Catheters, Mexico, Distribution Share (2010-2011) 58 6.2.2 Infusion Systems, Mexico, Distribution Share (2010-2011) 58 6.2.3 Metered Dose Inhaler Devices, Mexico, Distribution Share (2010-2011) 59 6.2.4 Needle Free Injections, Mexico, Distribution Share (2010-2011) 59

6.3 Drug Delivery Devices, Mexico, Company Share (2010-2011) 60 6.3.1 Drug Delivery Devices, Mexico, Company Share (2010-2011) 60 6.3.2 Central Venous Catheters, Mexico, Company Share (2010-2011) 62 6.3.3 Infusion Systems, Mexico, Company Share (2010-2011) 64 6.3.4 Metered Dose Inhaler Devices, Mexico, Company Share (2010-2011) 66 6.3.5 Needle Free Injections, Mexico, Company Share (2010-2011) 67

7 Overview of Key Companies in South and Central America Drug Delivery Devices Market 68

7.1 GlaxoSmithKline plc 68 7.1.1 Company Overview 68 7.1.2 Share in the South and Central America Drug Delivery Devices Market 68

7.2 Boehringer Ingelheim GmbH 69 7.2.1 Company Overview 69 7.2.2 Share in the South and Central America Drug Delivery Devices Market 69

7.3 AstraZeneca PLC 70 7.3.1 Company Overview 70





7.3.2 Share in the South and Central America Drug Delivery Devices Market 70

7.4 Baxter International Inc. 71 7.4.1 Company Overview 71 7.4.2 Share in the South and Central America Drug Delivery Devices Market 71

7.5 Hospira, Inc. 72 7.5.1 Company Overview 72 7.5.2 Share in the South and Central America Drug Delivery Devices Market 72

7.6 B. Braun Melsungen AG 73 7.6.1 Company Overview 73 7.6.2 Share in the South and Central America Drug Delivery Devices Market 73

7.7 Fresenius Kabi AG 74 7.7.1 Company Overview 74

7.8 Teleflex Incorporated 74 7.8.1 Company Overview 74

7.9 Terumo Corporation 74 7.9.1 Company Overview 74

7.10 Medtronic, Inc. 75 7.10.1 Company Overview 75

7.11 Smiths Medical 75 7.11.1 Company Overview 75

7.12 CareFusion Corporation 75 7.12.1 Company Overview 75

7.13 3M Health Care Ltd. 76 7.13.1 Company Overview 76

7.14 C. R. Bard, Inc. 76 7.14.1 Company Overview 76

7.15 Edwards Lifesciences Corporation 76 7.15.1 Company Overview 76

7.16 Consort Medical plc 77 7.16.1 Company Overview 77

7.17 Arcomed AG 77





7.17.1 Company Overview 77

7.18 Nipro Corporation 77 7.18.1 Company Overview 77

7.19 Universal Medical Technologies Inc. 78 7.19.1 Company Overview 78

7.20 Becton, Dickinson and Company 78 7.20.1 Company Overview 78

7.21 Cook Medical Incorporated 78 7.21.1 Company Overview 78

7.22 INJEX - Equidyne Systems 79 7.22.1 Company Overview 79

7.23 Samtronic 79 7.23.1 Company Overview 79

7.24 Lifemed Ind. de Equipamentos e Art. Medicos Hospitalares S.A 79 7.24.1 Company Overview 79

7.25 PharmaJet, Inc. 79 7.25.1 Company Overview 79

8 Drug Delivery Devices Market Pipeline Products 80

9 Financial Deals Landscape 85

9.1 Partnerships 85 9.1.1 Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 85 9.1.2 Echo Therapeutics Expands Licensing Agreement With Ferndale Pharma 86

10 Appendix 87

10.1 Definitions of Markets Covered in the Report 88 10.1.1 Drug Delivery Devices 88

10.2 Research Methodology 89

10.3 Secondary Research 89

10.4 Primary Research 89





10.5 Models 90

10.6 Forecasts 90

10.7 Expert Panels 90

10.8 GlobalData Consulting 91

10.9 Currency Conversion 91

10.10 Disclaimer 91

1.1 List of Tables Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 ..................... 10

Table 2: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 ....... 12

Table 3: Drug Delivery Devices, South and Central America, Cross-Category Analysis, 2004-2018 ............................. 13

Table 4: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ................................................................................................................................................................................... 15

Table 5: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ................................................................................................................................................................................... 17

Table 6: Drug Delivery Devices, South and Central America, Company share by Revenue ($m), USD Constant, 2010-2011 ................................................................................................................................................................................... 19

Table 7: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 .................................... 21

Table 8: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ..................... 23

Table 9: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ................... 25

Table 10: Central Venous Catheters, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ..... 26

Table 11: Infusion Systems, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 .................... 26

Table 12: Metered Dose Inhaler Devices, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011............................................................................................................................................................................................ 27

Table 13: Needle Free Injections, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ........... 27

Table 14: Drug Delivery Devices, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 .............. 29

Table 15: Central Venous Catheters, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 ........ 31

Table 16: Infusion Systems, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 ...................... 33

Table 17: Metered Dose Inhaler Devices, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011. 34

Table 18: Needle Free Injections, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 ............. 35

Table 19: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 ......................................... 37

Table 20: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 .......................... 39

Table 21: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ........................ 41

Table 22: Central Venous Catheters, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ............ 42

Table 23: Infusion Systems, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 .......................... 42

Table 24: Metered Dose Inhaler Devices, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 .... 43





Table 25: Needle Free Injections, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ................. 43

Table 26: Drug Delivery Devices, Brazil, Company Share, USD Constant, (2010-2011) ................................................ 45

Table 27: Central Venous Catheters, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 .............. 47

Table 28: Infusion Systems, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 ............................. 49

Table 29: Metered Dose Inhaler Devices, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 ....... 50

Table 30: Needle Free Injections, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 .................... 51

Table 31: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 ...................................... 53

Table 32: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Historic, 2004-2011........................ 55

Table 33: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ..................... 57

Table 34: Central Venous Catheters, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ......... 58

Table 35: Infusion Systems, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ........................ 58

Table 36: Metered Dose Inhaler Devices, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 .. 59

Table 37: Needle Free Injections, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ............... 59

Table 38: Drug Delivery Devices, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 .................. 61

Table 39: Central Venous Catheters, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 ............ 63

Table 40: Infusion Systems, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011........................... 65

Table 41: Metered Dose Inhaler Devices, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 ..... 66

Table 42: Needle Free Injections, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 .................. 67

Table 43: Drug Delivery DevicesMarket Pipeline Products ............................................................................................... 80

Table 44: Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System ................. 85

Table 45: Echo Therapeutics Expands Licensing Agreement With Ferndale Pharma .................................................... 86

1.2 List of Figures Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018................... 10

Figure 2: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 ...... 11

Figure 3: Drug Delivery Devices, South and Central America, Cross-Category Analysis, by Revenue ($m), USD Constant, 2004-2018......................................................................................................................................................... 13

Figure 4: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ................................................................................................................................................................................... 14

Figure 5: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ................................................................................................................................................................................... 16

Figure 6: Drug Delivery Devices, South and Central America, Company share (%), 2011 ............................................. 18

Figure 7: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 ................................... 20

Figure 8: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-2011 .................... 22

Figure 9: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 .................. 24

Figure 10: Drug Delivery Devices, Argentina, Company Share (%), 2011 ....................................................................... 28

Figure 11: Central Venous Catheters, Argentina, Company Share (%), 2011 ................................................................. 30

Figure 12: Infusion Systems, Argentina, Company Share (%), 2011 ................................................................................ 32

Figure 13: Metered Dose Inhaler Devices, Argentina, Company Share (%), 2011 .......................................................... 34





Figure 14: Needle Free Injections, Argentina, Company Share (%), 2011 ....................................................................... 35

Figure 15: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 ....................................... 36

Figure 16: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ......................... 38

Figure 17: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ....................... 40

Figure 18: Drug Delivery Devices, Brazil, Company Share (%), 2011 .............................................................................. 44

Figure 19: Central Venous Catheters, Brazil, Company Share (%), 2011 ........................................................................ 46

Figure 20: Infusion Systems, Brazil, Company Share (%), 2011 ...................................................................................... 48

Figure 21: Metered Dose Inhaler Devices, Brazil, Company Share (%), 2011 ................................................................ 50

Figure 22: Needle Free Injections, Brazil, Company Share (%), 2011 ............................................................................. 51

Figure 23: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 ..................................... 52

Figure 24: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ...................... 54

Figure 25: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 .................... 56

Figure 26: Drug Delivery Devices, Mexico, Company Share (%), 2011 ........................................................................... 60

Figure 27: Central Venous Catheters, Mexico, Company Share (%), 2011 ..................................................................... 62

Figure 28: Infusion Systems, Mexico, Company Share (%), 2011 .................................................................................... 64

Figure 29: Metered Dose Inhaler Devices, Mexico, Company Share (%), 2011 .............................................................. 66

Figure 30: Needle Free Injections, Mexico, Company Share (%), 2011 ........................................................................... 67

Figure 31: GlaxoSmithKline plc, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 ................................................................................................................................................................................... 68

Figure 32: Boehringer Ingelheim GmbH, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 ...................................................................................................................................................................... 69

Figure 33: AstraZeneca PLC, Company Share (%), South and Central America Drug Delivery Devices Market, 201170

Figure 34: Baxter International Inc., Company Share (%), South and Central America Drug Delivery Devices Market, 2011 ................................................................................................................................................................................... 71

Figure 35: Hospira, Inc., Company Share (%), South and Central America Drug Delivery Devices Market, 2011 ........ 72

Figure 36: B. Braun Melsungen AG, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 ................................................................................................................................................................................... 73

SAMPLEIntroduction




2 Introduction GlobalData’s medical equipment market reports are ideal guide for anyone wishing to understand their market better in terms of revenue, distribution share and company share.

2.1 What is This Report About? South and Central America drug delivery devices report provides an overview and the following information:

1. Comprehensive data related to the market revenue, company share and distribution share. 2. Global corporate-level profiles of key companies operating in the drug delivery devices

market in South and Central America. The profile includes a brief overview of the company. The selection of the companies is based on their operational presence in South and Central America. This includes key multinationals as well as key local players.

3. A list of key products under development by different companies. The selection of this list is based on the territory in which these products are being clinically investigated.

Note: “South and Central America;” comprises the following countries – Argentina, Brazil and Mexico.

SAMPLE

South and Central America Drug Delivery Devices




3 Drug Delivery Devices in South and Central America

3.1 Drug Delivery Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018

Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018

Source: GlobalData

Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018

Country Name 2004 2011 2018 CAGR 04-11 CAGR 11-18 CAGR 04-18

Source: GlobalData

SAMPLE





3.2 Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018

Figure 2: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018

Source: GlobalData

SAMPLE





Table 2: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018

Category 2004 2011 2018 CAGR 04-11 CAGR 11-18 CAGR 04-18

Source: GlobalData

SAMPLEAppendix



© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 87

10 Appendix The data and analysis within this report is driven by Medical eTrack

Medical eTrack gives you the key information to drive sales, investment and deal making activity in your business. It includes the following information:

15,000+ Market size data tables across 740 medical equipment segments and 39 countries with historic data from 2004 forecast to 2018

6,000+ Primary expert interviews conducted per annum for ensuring data and report quality

1,100+ Conferences on medical equipment covered

1,000+ Industry leading reports per annum covering growing sectors, market trends, investment opportunities and competitive landscape

600+ Analysis reports covering market and pipeline product analysis reports by indication, medical equipment trends and issue reports and investment and M&A trend reports worth over $3 Million

43,000+ Medical equipment companies profiled

1,500+ Private, emerging and technology start-up company profiles

1,500+ Medical equipment manufacturers in China and India

1,500+ Medical equipment companies in Japan

700+ Companies with revenue splits and market shares by category

1,500+ Quarterly and annual medical equipment company financials

700+ Medical equipment company SWOT’s

9,000+ Pipeline product profiles

8,000+ Marketed product profiles

14,000+ Clinical trials

15,000+ Trial investigators

13,000+ New product patents

3,300+ Companies with products in development

17,000+ Deals in the medical equipment industry 1,100+ Surgical and diagnostic procedures by therapy area

40+ Key healthcare indicators by country o For more information or to receive a free demo of the service visit

http://www.medicaletrack.com/contactus.aspx?RD=Demo=

SAMPLEAppendix




10.1 Definitions of Markets Covered in the Report 10.1.1 Drug Delivery Devices

Drug delivery devices are used for administration of drug compounds in effective ways. They include both hospital and home care devices. Metered dose inhaler devices, central venous catheters, needle free injections and infusion systems are tracked under this market.

10.1.1.1 Central Venous Catheters

A central venous catheter is a long, thin, flexible tube used to administer medicines, fluids, nutrients, or blood products and to monitor haemodynamic status of the patients in surgical and critical care settings over a long period of time, usually several weeks or more. These come in different sizes. Antimicrobial & Non antimicrobial central venous catheters are included under this category.

10.1.1.2 Infusion Systems

Infusion systems are used to administer medication to a patient in critical care, emergency care, home care and trauma centres. Volumetric pumps, syringe pumps, ambulatory infusion pumps, implantable infusion pumps and infusion disposable sets are tracked under this category.

10.1.1.3 Metered Dose Inhaler Devices

Metered dose inhaler devices deliver a specific amount of medication to the lungs. A metered-dose inhaler consists of a canister, the metering valve and an actuator.

10.1.1.4 Needle Free Injections

Needle-free Injections are the devices that do not use a needle to administer medication. They propel a small jet of liquid or powder at high speed through a microscopic orifice causing it to penetrate the skin for subcutaneous, intra-dermal, or intramuscular administration. Disposable needle free syringes are not tracked in this category. Needle free injection comprises of three parts - durable injector, disposable vial adapter and needle free syringes. Disposable components like vial adapters and syringes that come only with the first purchase of needle free syringe system is tracked and disposable components for subsequent use of the injectors are not tracked. Pre filled needle-free injections are not covered under this category. One unit refers to one needle free injection.

Note: 1). Value, distribution and company shares figures reflect annual gross sales of drug delivery devices in local currency converted to $ at constant rate. The annual growth (year on year growth) and compounded annual growth rate (CAGR) in tables is rounded off to one decimal place.

2). Company share data represents market share (in revenues and as percentage to total market) of companies in market categories and geographies tracked. The data is rounded off to the nearest decimal places.

SAMPLEAppendix




10.2 Research Methodology GlobalData’s dedicated Research and Analysis Teams consists of qualified professionals with experience in marketing, market research, consulting background in the medical devices industry and advanced statistical expertise.

GlobalData adheres to the Codes of Practice of the Market Research Society (www.mrs.org.uk) and the Strategic and Competitive Intelligence Professionals (www.scip.org).

All GlobalData databases are continuously updated and revised. The following research methodology is followed for all databases and reports.

10.3 Secondary Research The research process begins with exhaustive secondary research on internal and external sources being carried out to source qualitative and quantitative information relating to each market.

The secondary research sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings;

Industry trade journals, scientific journals and other technical literature;

Internal and external proprietary databases;

Relevant patent and regulatory databases;

National government documents, statistical databases and market reports;

Procedure registries; and

News articles, press releases and web-casts specific to the companies operating in the market.

10.4 Primary Research GlobalData conducts thousands of interviews a year with industry participants and commentators in order to validate its data and analysis. A typical research interview fulfills the following functions:

It provides first-hand information on market size, market trends, growth trends, competitive landscape and future outlook;

Helps in validating and strengthening the secondary research findings; and

Further develops the analysis team’s expertise and market understanding.

Primary research involves e-mail interactions and telephonic interviews for each market, category, segment and sub-segment across geographies.

The participants who typically take part in such a process include, but are not limited to:

Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers;

SAMPLEAppendix




Hospital stores, laboratories, pharmacies, distributors and paramedics;

Outside experts: investment bankers, valuation experts, research analysts specializing in specific medical equipment markets; and

Key opinion leaders: physicians and surgeons specializing in different therapeutic areas corresponding to different kinds of medical equipment.

10.5 Models Where no hard data is available, GlobalData uses modeling and estimates in order to produce comprehensive data sets. The following rigorous methodology is adopted:

Available hard data is cross-referenced with the following data types to produce estimates:

Demographic data on population segments;

Macro-economic indicators such as GDP, inflation rate;

Healthcare indicators such as health expenditure, physician base, healthcare infrastructure and facilities; and

Selected epidemiological and procedure statistics.

10.6 Forecasts GlobalData uses proprietary forecast models. The following four factors are utilized in the forecast models:

Historic growth rates;

Macro-indicators such as population trends and healthcare spending;

Forecast epidemiological data; and

Qualitative trend information and assumptions.

The data is then cross-checked by the expert panel.

10.7 Expert Panels GlobalData uses a panel of experts to cross verify its databases and forecasts.

GlobalData’s expert panel comprises marketing managers, product specialists, international sales managers from medical device companies; academics from research universities, KOLs from hospitals, consultants from venture capital funds and distributors/suppliers of medical equipment and supplies etc.

Historic data and forecasts are relayed to GlobalData’s Expert Panel for feedback and adjusted in accordance with their feedback.

SAMPLEAppendix




10.8 GlobalData Consulting We hope that the data and analysis in this brief will help you make informed and imaginative business decisions. If you have further requirements, GlobalData’s consulting team may be able to help you. GlobalData offers tailor-made analytical and advisory services to drive your key strategic decisions.

10.9 Currency Conversion The Currency Conversion rate is based on 2011 average rate. 1 USD =

Argentina 4.546 ARS. Brazil 1.954 BRL.

Mexico 13.158 MXN.

10.10 Disclaimer All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, GlobalData.

gdme0222rdb - south and central america drug delivery ... · sample south and central america drug...

Documents